Conocimiento, tratamiento y control de la presión arterial según lugar de reclutamiento y sexo en la encuesta May Measure Month 2018 en España

Gijón-Conde, Teresa; Rodilla, Enrique; Molinero, Ana; Alvargonzález, M.; Ruilope, Luis

doi:10.1016/j.hipert.2020.07.003

Cited by 5 publications

(2 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…With regard to treatment, 6.1% of patients did not take any drug, 38.8% were taking one prescribed antihypertensive drug, 35% two antihypertensive drugs and 20% three or more prescribed drugs. Our results show the trends in Spain, where we observed an increase in BP control from 36% in 2002 to 46% in 2010 among hypertensive patients treated by primary care physicians ( 27 ), mainly related with a progressive higher use of combination therapy (from 44% to 64%) ( 27 ), similarly to other studies describing a direct relationship between the use of combination treatment and improvement of BP control (60%–65%) ( 13 , 28 ). Even considering a great variability among different countries ( 4 ), BP control rates have remained stable in the last decade in the world (30%–50%), despite the improvement in detection, awareness, treatment and control of BP in high-income countries along the 80s and 90s ( 5 ).…”

Section: Discussionsupporting

confidence: 87%

Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study

Prieto-Díaz,

Pallares-Carratala,

Manuel Micó-Pérez

et al. 2023

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

ObjectivesTo determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort.MethodsIBERICAN is an ongoing prospective cohort study, whose primary objective is to determine the frequency, incidence, and distribution of CVRF in the adult Spanish population seen in primary care settings. This analysis shows the baseline clinical characteristics of patients with hypertension. Adequate BP control was defined as BP <140/90 mmHg according to 2013 ESH/ESC guidelines.ResultsA total of 8,066 patients were consecutively included, of whom 3,860 (48.0%) had hypertension. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 years; p < 0.001), had more cardiovascular risk factors, target organ damage and cardiovascular disease (CVD) in comparison with those without hypertension. The risk of hypertension increased with the presence of associated CV risk factors and comorbidities, particularly diabetes, obesity and the metabolic syndrome, and decreased with the intensity of physical activity. Regarding antihypertensive treatments, 6.1% of patients did not take any medication, 38.8% were taking one antihypertensive drug, 35.5% two drugs, and 19.6% three or more antihypertensive drugs. Overall, 58.3% achieved BP goals <140/90 mmHg. A greater probability of BP control was observed with increasing age of patients and the greater number of antihypertensive drugs. Blood pressure control was lower in hypertensive patients with diabetes, obesity, the metabolic syndrome, increased urinary albumin excretion, higher pulse pressure, and lack of antihypertensive treatment.ConclusionsAbout half of patients attended in primary care settings have hypertension in Spain. Patients with hypertension have a worse CV clinical profile than non-hypertensive patients, with greater association of CVRF and CVD. Around four out of ten patients do not achieve the recommended BP goals, and higher use of combination therapies is associated with a better BP control.

show abstract

Section: Discussionsupporting

confidence: 87%

Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study

Prieto-Díaz,

Pallares-Carratala,

Manuel Micó-Pérez

et al. 2023

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…Experiencias como el May Measurement Month (MMM) liderada por la International Society of Hypertension (ISH) en la que se muestran resultados a nivel internacional, incluyendo a España, avalan la utilidad de la farmacia comunitaria como un punto importante de cribado de la HTA (7,8), con muchos trabajos publicados al respecto (9). La última Guía Europea de Hipertensión ESC (10) y el Documento de consenso de 2021 (11) resaltan la importancia de los farmacéuticos comunitarios en el cribado y seguimiento de los pacientes con hipertensión dentro de un enfoque multidisciplinar compartido.…”

Section: Cribado Justificaciónunclassified